Tonix Pharmaceuticals Holding Corp. (TNXP)
19.29
-0.34
(-1.73%)
USD |
NASDAQ |
Dec 12, 16:00
19.29
0.00 (0.00%)
After-Hours: 20:00
Tonix Pharmaceuticals Research and Development Expense (TTM): 35.84M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amgen, Inc. | 6.828B |
| Amicus Therapeutics, Inc. | 142.29M |
| Vertex Pharmaceuticals, Inc. | 3.954B |
| Soligenix, Inc. | 8.144M |
| GeoVax Labs, Inc. | 22.74M |